If you have been planning to get a flu shot but just haven’t gotten around to it yet, the time to act is now — especially if you hope to be healthy at Christmas.
The finding from the largest head-to-head study to date between two leading drugs to treat opioid addiction could dramatically change prescribing habits.
A wearable device claiming to block the pain of opioid withdrawal has been cleared by the Food and Drug Administration under a new expedited review process.
Mark Smith wants to inject his dying daughter with a virus in hopes it might kill the bacteria rooted in her lungs. First, he has to find the right virus.
New findings highlight just how hard it has been for the FDA to keep potentially unsafe supplement ingredients off the market.
New interior design programs train students to use lighting, acoustics, and fabric to make day-to-day living easier for people with medical conditions.
The time of day of your surgery could have long-term impacts on your health.
The danger of natural disasters lies not only in the tremendous loss of life and property, but also in the psychological toll they take on survivors.
An experimental vaccine meant to combat peanut allergy came up short in a large clinical trial, but the company still hopes it can win FDA approval.
As the first gene therapies approach the market, drug makers, insurers, and patients are debating complex questions about cost, value, and payment plans.
